公告修正管制藥品品項(增列7-Hydroxymitragynine等3項管制藥品)
公告修正管制藥品品項(增列7-Hydroxymitragynine等3項管制藥品)
Publisher
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
公告修正管制藥品品項(增列7-Hydroxymitragynine等3項管制藥品)
Source route
Continue on fda.gov.tw
Leave the platform to read the original full article on the publisher site.
Source: TFDA Taiwan
Scope: Regulatory
Related coverage
More related coverage
Decision: Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients
Public list of companies in the UK who have had their licence/registration to manufacture or wholesa...
Guidance: Archiving and retention of clinical trial records
Information on clinical trial record retention and archiving requirements including requirements for...
Guidance: Declaration of Helsinki and Clinical Trial Regulations alignment
Information on the alignment of the amended UK clinical trial legislation with the Declaration of He...
Guidance: Clinical Trials Regulations enforcement provisions
Information about Clinical Trials Regulations outlining expanded enforcement provisions, offences, a...